Related
US experts back HIV drug for preventive treatment 
Laugh yourself healthy 
Alzheimer’s studied in veteran US soldiers 
US health officials warn on breast implants 
HIV vaccine on trial US healthcare giant Johnson and Johnson is talking to Dutch biotech company Crucell about buying the shares in the firm it does not already own for 1.75 billion euros.
Johnson and Johnson wants to strengthen its vaccine business, and is offering a 58 percent premium on the share price. Crucell is one of only two major independent vaccine makers in Europe, the other being Austria’s Intercell.
More about: Health, Medical research, USACopyright © 2012 euronews
Top Stories
Mali: Rebel groups agree to creation of Islamic state
Two Rebel groups have agreed to merge and create an independent Islamic state in Northern Mali. After seizing Azawad – an area larger than France – two months ago, the groups had initially disagreed, with the secular Movement for the Liberation of Azawad (MNLA)…
International condemnation after Syria massacre
The United Nations has condemned the massacre of 92 civilians including 32 children in…
Egypt election: Shafiq vows no return to Mubarak era
One of the two candidates battling to become Egypt’s president has distanced himself from…
Corporate news
Aramco, Sumitomo plan petrochemical expansion- Nissan’s electric jobs promise for Spain
- Fees setback for MasterCard
- Air France-KLM talks job cuts with unions
- Sharing turns to suing over Facebook IPO
- Call it Miat or Fazda, it’s definitely sporty
- Bankia’s black hole to be plugged
- Yahoo cashes in Chinese stake
- Ryanair issues profits warning for 2013
- Writing on wall for Opel’s Bochum plant
euronews on facebook
